Calyx Chemicals & Pharmaceuticals Limited – FDA 483, Nov 4, 2019
CALYX CHEMICALS AND PHARMACEUTICALS LTD. in Boisar, India, an API manufacturer, was inspected by the FDA from November 4-8, 2019. The inspection revealed significant deficiencies in the firm's quality unit, including failures related to stability data, validation protocol approvals, critical deviation investigations, and laboratory control records for sample management. These issues indicate a lack of robust quality oversight and data integrity for active pharmaceutical ingredients and intermediates.
ID · e6c38ac1-c189-46f8-a4ef-26fdd8cf44ad
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.